If a doctor deems it medically necessary, Medicare Part D prescription drug plans may typically cover the costs of Dovonex (calcipotriene), but costs for the medication can vary.

Private insurance companies administer Part D prescription drug plans on Medicare’s behalf, and monthly premiums can start from $0. In addition to premiums, out-of-pocket costs may include coinsurance and annual deductibles.

Per Medicare rules, in 2025, Part D plan deductibles may not exceed $590.

If you have psoriasis, a doctor or healthcare professional may prescribe Dovonex (calcipotriene) that you can apply to your skin or scalp.

When medically necessary, Medicare Part D can typically cover the costs of Dovonex.

Part D drug plans have three stages of coverage, which are the:

  • deductible stage
  • initial coverage stage
  • catastrophic coverage stage

The deductible stage

Not all Part D plans have a deductible, but you may begin at this stage if they do.

You may pay the deductible in full before the plan pays its percentage of eligible costs.

The initial coverage stage

At this stage, you may pay a 25% coinsurance toward the cost of brand-name and generic medications.

You may continue to pay the 25% coinsurance until you pay a total of $2,000 in 2025. This cost may increase to $2,100 in 2026.

The catastrophic coverage stage

At this stage, you may pay no further medication costs for the remainder of the calendar year.

You may receive an explanation of benefits (EOB) the month after your pharmacy sends a bill to your plan provider. The EOB usually details:

  • filled prescriptions you have
  • how much both the plan and you have paid
  • the amount you have paid that counts toward your out-of-pocket total
  • other contributors, such as another insurer
  • the coverage stage
  • your total drug costs

Dovonex is one of the brand names for the topical medication calcipotriene.

A doctor may prescribe this medication to treat plaque psoriasis, an autoimmune disease in which the immune system attacks healthy tissues and cells.

The medication is part of a drug class called synthetic vitamin D derivatives and is currently available as Dovonex (calcipotriene) topical cream and ointment.

Dovonex was available as a topical solution. However, the manufacturer discontinued this product. Generic versions may still be available.